Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.230
-0.040 (-0.94%)
Aug 5, 2026, 3:39 PM EDT - Market open
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $253.3 million as of August 5, 2026. Its market cap has increased by 75.18% in one year.
Market Cap
253.30M
Enterprise Value
174.14M
1-Year Change
75.18%
Ranking
Category
Stock Price
$4.23
ChartMarket Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $253.30M, an increase of 28.29%. That is a compound annual growth rate of 4.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 253.30M | 8.09% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eledon Pharmaceuticals | 269.79M |
| ALX Oncology Holdings | 265.09M |
| InflaRx | 262.18M |
| Entrada Therapeutics | 260.88M |
| ProQR Therapeutics | 257.55M |
| Surrozen | 255.43M |
| MacroGenics | 247.90M |
| Capricor Therapeutics | 241.49M |